The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement
Health Secretary highlights the need for capacity building programmes for Medical Officers to tackle Non Communicable Diseases at the primary level
Under the terms of the VPPA, IGNIS will produce renewable energy equal to Lonza’s electricity needs across Switzerland and the European Union.
The new recycling facility, Recover Louth, is the second addition to Coveris’ closed loop recycling business segment
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
Jain will have oversight of Brinton's domestic operations, including business development, sales, and marketing
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
The successful outcome of this study represents an important milestone in Dr. Reddy's commitment to make highquality biosimilar products more accessible and affordable
Subscribe To Our Newsletter & Stay Updated
